Patents by Inventor Thierry Canton

Thierry Canton has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of alzheimer's disease
    Publication number: 20040138145
    Abstract: The subject of the invention is the application of intestinal biliary acid reuptake inhibitors for the prevention and treatment of Alzheimer's disease, where appropriate, in combination with an HMG-CoA reductase inhibitor, a cholesterol uptake inhibitor, a cholesterol synthesis inhibitor or an APP secretase inhibitor.
    Type: Application
    Filed: December 12, 2003
    Publication date: July 15, 2004
    Applicant: Aventis Pharma S.A.
    Inventors: Thierry Canton, Laurent Pradier, Jesus Benavides, Hubert Heuer, Hans-Ludwig Schaefer
  • Use of 2-amino-6-trifluoromethoxybenzothiazole for the prevention or treatment of cerebellar dysfunction
    Patent number: 6245791
    Abstract: A method for the prevention or treatment of cerebellar dysfunction, particularly cerebellar ataxia, by the use of riluzole or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: August 3, 2000
    Date of Patent: June 12, 2001
    Assignee: Aventis Pharma S.A.
    Inventors: Andrees Bohme, Alain Boireau, Thierry Canton, Assunta Imperato